메뉴 건너뛰기
Oncologist
Volumn 13, Issue 12, 2008, Pages 1314-
Osteonecrosis of the jaw and the use of antiangiogenic agents: Just an association?
Author keywords

[No Author keywords available]
Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; BISPHOSPHONIC ACID DERIVATIVE; DOCETAXEL; PREDNISONE; THALIDOMIDE; ZOLEDRONIC ACID;
EID: 58749084313     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2008-0206     Document Type: Letter
Times cited : (8)
References (6)
  • 1
    • 50649114676 scopus 로고    scopus 로고
    • Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy
    • Estilo CL, Van Poznak CH, Wiliams T et al. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. The Oncologist 2008;13:911-920.
    • (2008) The Oncologist , vol.13 , pp. 911-920
    • Estilo, C.L.1    Van Poznak, C.H.2    Wiliams, T.3
  • 2
    • 27344453813 scopus 로고    scopus 로고
    • Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment
    • Marx RE, Sawatari Y, Fortin M et al. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567-1575.
    • (2005) J Oral Maxillofac Surg , vol.63 , pp. 1567-1575
    • Marx, R.E.1    Sawatari, Y.2    Fortin, M.3
  • 3
    • 50649084271 scopus 로고    scopus 로고
    • Osteonecrosis of the jaw (ONJ) in androgen-independent prostate cancer (AIPC) patients receiving ATTP (bevacizumab, docetaxel, thalidomide, and prednisone)
    • Aragon-Ching JB, Ning YM, Latham L et al. Osteonecrosis of the jaw (ONJ) in androgen-independent prostate cancer (AIPC) patients receiving ATTP (bevacizumab, docetaxel, thalidomide, and prednisone). J Clin Oncol 2007;25:19594.
    • (2007) J Clin Oncol , vol.25 , pp. 19594
    • Aragon-Ching, J.B.1    Ning, Y.M.2    Latham, L.3
  • 4
    • 58749103044 scopus 로고    scopus 로고
    • Higher incidence of osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents
    • in press
    • Aragon-Ching JB, Ning YM, Chen C et al. Higher incidence of osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents. Cancer Invest 2008 (in press).
    • (2008) Cancer Invest
    • Aragon-Ching, J.B.1    Ning, Y.M.2    Chen, C.3
  • 5
    • 0036721078 scopus 로고    scopus 로고
    • Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid
    • Wood J, Bonjean K, Ruetz S et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002;302:1055-1061.
    • (2002) J Pharmacol Exp Ther , vol.302 , pp. 1055-1061
    • Wood, J.1    Bonjean, K.2    Ruetz, S.3
  • 6
    • 50549088915 scopus 로고    scopus 로고
    • Osteonecrosis of the jaw related to bevacizumab
    • Estilo CL, Fornier M, Farooki A et al. Osteonecrosis of the jaw related to bevacizumab. J Clin Oncol 2008;26:4037-4038.
    • (2008) J Clin Oncol , vol.26 , pp. 4037-4038
    • Estilo, C.L.1    Fornier, M.2    Farooki, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.